Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer
出版年份 2020 全文链接
标题
Using next‐generation sequencing to redefine
BRCAness
in triple‐negative breast cancer
作者
关键词
-
出版物
CANCER SCIENCE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-01-21
DOI
10.1111/cas.14313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic landscape in mutational triple negative breast cancer
- (2018) Yaqin Shi et al. Molecular Cancer
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
- (2018) Theo A. Knijnenburg et al. Cell Reports
- Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database
- (2017) Chang Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
- (2017) Marilyn M. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer
- (2017) Robert W Mutter et al. JOURNAL OF PATHOLOGY
- Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor
- (2017) Masatoshi Takagi et al. JNCI-Journal of the National Cancer Institute
- A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
- (2017) Paz Polak et al. NATURE GENETICS
- Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
- (2017) Jian Yuan Goh et al. NATURE MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
- (2017) X Bian et al. ONCOGENE
- DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers
- (2017) Mahsa Javid et al. WORLD JOURNAL OF SURGERY
- Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor
- (2017) Masatoshi Takagi et al. JNCI-Journal of the National Cancer Institute
- A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
- (2017) Po-Han Lin et al. Cancer Medicine
- A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy
- (2017) Jun Qian et al. Scientific Reports
- Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germlineBRCA1/2mutation: a multistudy analysis of response rates and safety
- (2016) U. A. Matulonis et al. ANNALS OF ONCOLOGY
- BRCA1 -Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency
- (2016) Esther H. Lips et al. CLINICAL CANCER RESEARCH
- Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
- (2016) Wen-Chi Chou et al. International Journal of Biological Sciences
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer
- (2016) L. Leichman et al. ONCOLOGIST
- Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
- (2016) Po-Han Lin et al. Oncotarget
- A patient with polymerase E1 deficiency (POLE1): clinical features and overlap with DNA breakage/instability syndromes
- (2015) Isabelle Thiffault et al. BMC Medical Genetics
- Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer
- (2015) Grace O. Silva et al. BREAST CANCER RESEARCH AND TREATMENT
- Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
- (2015) Gretchen K. Hubbard et al. CANCER RESEARCH
- Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
- (2015) Melinda L. Telli et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
- (2015) Steven J. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple negative breast cancer: looking for the missing link between biology and treatments
- (2015) Giuseppe Palma et al. Oncotarget
- Effects of BRCA1- and BRCA2-Related Mutations on Ovarian and Breast Cancer Survival: A Meta-analysis
- (2014) Q. Zhong et al. CLINICAL CANCER RESEARCH
- Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing
- (2014) Yanming Feng et al. GENETICS IN MEDICINE
- Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro
- (2014) Romana Koppensteiner et al. PLoS One
- Vulnerabilities of PTEN-TP53-Deficient Prostate Cancers to Compound PARP-PI3K Inhibition
- (2014) E. Gonzalez-Billalabeitia et al. Cancer Discovery
- Genetic Susceptibility to Triple-Negative Breast Cancer
- (2013) K. N. Stevens et al. CANCER RESEARCH
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
- (2013) A. Min et al. MOLECULAR CANCER THERAPEUTICS
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
- (2012) V Abkevich et al. BRITISH JOURNAL OF CANCER
- The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
- (2010) V. J. Weston et al. BLOOD
- Lynch Syndrome-Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry
- (2010) M. D. Walsh et al. CLINICAL CANCER RESEARCH
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
- (2008) B. Evers et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More